Newsroom


Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility

DURHAM, NC – January 18, 2023 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today…

Read More

Robert Claypoole Named CEO

Seasoned Leader Brings More than Two Decades of Medical Device Experience and Proven Track Record of Driving Revenue and Operating Margin Growth…

Read More

Bioventus Agrees to Nationwide Contract with Aetna Medicare Advantage Plans for DUROLANE for Knee Osteoarthritis

DURHAM, NC – Dec. 5, 2023 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…

Read More

Bioventus Announces Divestiture of its Wound Business

DURHAM, N.C., May 10, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active…

Read More

Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago

Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago Full Launch of BoneScalpel Access® at NASS DURHAM, NC –…

Read More

Bioventus Completes CartiHeal Acquisition

Bioventus Completes CartiHeal Acquisition DURHAM, NC – July 12, 2022 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader…

Read More

Bioventus Amends CartiHeal Acquisition Structure

Bioventus Amends CartiHeal Acquisition Structure  DURHAM, NC – June 21, 2022 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global…

Read More

Bioventus Exercises Call Option to Acquire CartiHeal

DURHAM, NC – April 4, 2022 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today…

Read More

Bioventus Receives 510(k) Clearance for StimRouter Pain Management Device

Industry Leading Peripheral Nerve Stimulator Upgraded to Improve Patient User Experience with Control of their Unique Chronic Pain Condition, Longer…

Read More

Bioventus Appoints Mark Singleton as Chief Financial Officer

DURHAM, NC – February 28, 2022 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing,…

Read More

Search News


Download Library


Corporate and Brand Logos
Download Now

Product Images
Download Now